3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to initial data suggesting different biological properties. Present studies demonstrate that 3-HPC may possess separate responses on the brain click here system, potentially playing a role to some of the unexpected reactions linked